CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 52 enrolled
Drug / intervention
Ropivacaine 0.2% Injectable Solution +2 moredrug
Likely dose
Ropivacaine 0.2% Injectable Solution 1.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05688670
NCT05688670Phase 4Completed
CompareCT.gov

Pain Control With Regional Anesthesia Following Pediatric Cardiac Surgery: A Randomized Double-Blinded Pilot Study

Duke University·interventional·Posted Jan 18, 2023·Updated Aug 28, 2025

In Brief

A Phase 4 clinical trial evaluating Regional Anesthesia, Wound infiltration, and 1 other intervention for Atrial Septal Defect and 2 related conditions. Completed, enrolled 52 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate pain control following pediatric cardiac surgery with the use of local anesthesia via an ultrasound guided regional anesthetic technique compared with surgeon delivered wound infiltration.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Septal Defect, Ventricular Septal Defect, Pain, Procedural
CountriesUnited States
CollaboratorsThe Society of Pediatric Anesthesia

Timeline

Phase 4CompletedFinished
2023202420252026
First PostedJan 18, 2023
Enrollment StartMar 29, 2023
Primary CompletionOct 18, 2024
Study CompletionJan 22, 2025
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 3.5 years ago

Interventions

Regional Anesthesiaprocedure

Bilateral pecto-intercostal fascial plane block (PIFB) and unilateral rectus sheath block (RSB) with Ropivacaine 0.2%

Wound infiltrationprocedure

Surgeon-delivered wound infiltration with Ropivacaine 0.2%

Ropivacaine 0.2% Injectable Solutiondrug

Ropivacaine 1.5 mL/kg will be used for both interventions